Applications: | Immunodepletion/Immunocompetition |
Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description : | CRMP1 Blocking Peptide for STJ500611 is synthetically produced from the 80-130 sequence and is suitable for use in western blot applications. |
Formulation: | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
Storage Instruction: | Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
Immunogen Region: | 80-130 |
Specificity: | This blocking peptide is recommended for use in combination with CRMP1 antibody, STJ500611 |
Immunogen: | Synthetic peptide corresponding to 80-130 on CRMP1 protein. |
Background | Hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides |
Information sourced from Uniprot.org